UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

Roles of metalloproteases in metastatic niche

Current molecular medicine, 2011-11, Vol.11 (8), p.609

2011

Volltextzugriff (PDF)

Rankl genetic deficiency and functional blockade undermine skeletal stem and progenitor cell differentiation

Stem cell research & therapy, 2024-07, Vol.15 (1), p.203-16, Article 203

2024

Volltextzugriff (PDF)

Acute changes in free and extracellular vesicle-associated circulating miRNAs and myokine profile in professional sky-runners during the Gran Sasso d’Italia vertical run

Frontiers in molecular biosciences, 2022-08, Vol.9, p.915080-915080

2022

Volltextzugriff (PDF)

Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases

Current cancer drug targets, 2010-11, Vol.10 (7), p.649

2010

Volltextzugriff (PDF)

Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment

Journal of medical genetics, 2006-04, Vol.43 (4), p.315-325

2006

Volltextzugriff (PDF)

An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6

Osteoporosis international, 2014-02, Vol.25 (2), p.681-692

2014

Volltextzugriff (PDF)

c-Src-mediated regulation of Penk1 signal controls osteoblast differentiation

Bone (New York, N.Y.), 2012-05, Vol.50, p.S71-S71

2012

Volltextzugriff (PDF)

Bone Metastasis Pain, from the Bench to the Bedside

International journal of molecular sciences, 2019-01, Vol.20 (2), p.280

2019

Volltextzugriff (PDF)

Chondroadherin prevents bone loss and inhibits tumor growth in animal models of osteoporosis and cancer-induced bone disease

Bone (New York, N.Y.), 2012-12, Vol.51 (6), p.S13-S13

2012

Volltextzugriff (PDF)

Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases

Gene therapy, 2005-04, Vol.12 (8), p.702-714

2005

Volltextzugriff (PDF)

Lipocalin2 is a new regulator of osteoblast functions in response to mechanical forces

Bone (New York, N.Y.), 2012-05, Vol.50, p.S42-S42

2012

Volltextzugriff (PDF)

Pre-clinical employment of the heparin binding domain of PRELP in the treatment of bone loss diseases

Bone (New York, N.Y.), 2012-05, Vol.50, p.S61-S61

2012

Volltextzugriff (PDF)

Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro

European journal of cancer (1990), 2003-09, Vol.39 (13), p.1927-1935

2003

Volltextzugriff (PDF)

978 Effects of 1D11 an Antibody Against Transforming Growth Factor Beta (TGF-b) on Incidence and Local Growth of Prostate Cancer Bone Metastases

European journal of cancer (1990), 2012-07, Vol.48, p.S236-S236

2012

Volltextzugriff (PDF)

976 Effects of Dual PI3K and mTOR Inhibition on Incidence and Local Growth of Prostate Cancer Bone Metastases

European journal of cancer (1990), 2012-07, Vol.48, p.S235-S235

2012

Volltextzugriff (PDF)

New experimental small interfering RNA therapy for autosomal dominant osteopetrosis

Bone (New York, N.Y.), 2010-06, Vol.47, p.S48-S48

2010

Volltextzugriff (PDF)

Regulatory loops involving IGFBP5 account for a fine tuning regulation of osteoblast and osteoclast activity in the context of the IL-6 pathway

Bone (New York, N.Y.), 2011-05, Vol.48, p.S107-S107

2011

Volltextzugriff (PDF)

FC-OPG prevents IL-6 dependent bone loss and impaired skeletal growth in IL-6 transgenic mice. implications for therapy in juvenile chronic inflammatory diseases

Bone (New York, N.Y.), 2010-06, Vol.47, p.S138-S139

2010

Volltextzugriff (PDF)

In vivo relevance of the interplay between IL-6 and C-SRC in the regulation of osteoblast function. Involvement of the IGF-1/IGFBPS axis

Bone (New York, N.Y.), 2010-06, Vol.47, p.S130-S130

2010

Volltextzugriff (PDF)

A new therapeutic approach to prevent oestrogen-withdrawal induced bone loss

Bone (New York, N.Y.), 2011-05, Vol.48, p.S226-S226

2011

Volltextzugriff (PDF)

New experimental therapy to rescue impaired skeletal growth and bone loss in a mouse model of IL-6 dependent juvenile inflammatory diseases

Bone (New York, N.Y.), 2011-05, Vol.48, p.S95-S95

2011

Volltextzugriff (PDF)

The heparin binding domain of the bone protein proline/arginine-rich end leucine-rich repeat protein (PRELP) counteracts bone loss in ovariectomised (OVX) mice

Bone (New York, N.Y.), 2010-06, Vol.47, p.S142-S143

2010

Volltextzugriff (PDF)

The integrin binding domain of chondroadherin is a potential new target for drug development to treat bone metastases, affecting the players of the vicious cycle

Bone (New York, N.Y.), 2010-06, Vol.47, p.S37-S37

2010

Volltextzugriff (PDF)

Role of RAMP2 and BSP2 in the c-Src-regulated osteomimicry of breast cancer bone metastasis

Bone (New York, N.Y.), 2009-06, Vol.44, p.S273-S273

2009

Volltextzugriff (PDF)

Inhibition of c-Src reduces IL-6 expression in vivo and in vitro

Bone (New York, N.Y.), 2009-06, Vol.44, p.S249-S249

2009

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(99)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Life Sciences & Biomedicine
(60)
Humans
(55)
Male
(51)
Female
(45)
Adult
(30)
Middle Aged
(27)
Animals
(25)
Biological And Medical Sciences
(23)
Orthopedics
(22)
Endocrinology & Metabolism
(18)
Aged
(17)
Medical Sciences
(16)
Mice
(15)
Psychiatry
(14)
Fundamental And Applied Biological Sciences. Psychology
(11)
Adolescent
(9)
Biochemistry & Molecular Biology
(9)
Bone Neoplasms - Secondary
(7)
Cells, Cultured
(7)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Roles of metalloproteases in metastatic niche

Rankl genetic deficiency and functional blockade undermine skeletal stem and progenitor cell differentiation

Acute changes in free and extracellular vesicle-associated circulating miRNAs and myokine profile in professional sky-runners during the Gran Sasso d’Italia vertical run

Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases

Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment

An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6

c-Src-mediated regulation of Penk1 signal controls osteoblast differentiation

Bone Metastasis Pain, from the Bench to the Bedside

Chondroadherin prevents bone loss and inhibits tumor growth in animal models of osteoporosis and cancer-induced bone disease

Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases

Lipocalin2 is a new regulator of osteoblast functions in response to mechanical forces

Pre-clinical employment of the heparin binding domain of PRELP in the treatment of bone loss diseases

Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro

978 Effects of 1D11 an Antibody Against Transforming Growth Factor Beta (TGF-b) on Incidence and Local Growth of Prostate Cancer Bone Metastases

976 Effects of Dual PI3K and mTOR Inhibition on Incidence and Local Growth of Prostate Cancer Bone Metastases

New experimental small interfering RNA therapy for autosomal dominant osteopetrosis

Regulatory loops involving IGFBP5 account for a fine tuning regulation of osteoblast and osteoclast activity in the context of the IL-6 pathway

FC-OPG prevents IL-6 dependent bone loss and impaired skeletal growth in IL-6 transgenic mice. implications for therapy in juvenile chronic inflammatory diseases

In vivo relevance of the interplay between IL-6 and C-SRC in the regulation of osteoblast function. Involvement of the IGF-1/IGFBPS axis

A new therapeutic approach to prevent oestrogen-withdrawal induced bone loss

New experimental therapy to rescue impaired skeletal growth and bone loss in a mouse model of IL-6 dependent juvenile inflammatory diseases

The heparin binding domain of the bone protein proline/arginine-rich end leucine-rich repeat protein (PRELP) counteracts bone loss in ovariectomised (OVX) mice

The integrin binding domain of chondroadherin is a potential new target for drug development to treat bone metastases, affecting the players of the vicious cycle

Role of RAMP2 and BSP2 in the c-Src-regulated osteomimicry of breast cancer bone metastasis

Inhibition of c-Src reduces IL-6 expression in vivo and in vitro

Suchergebnisse filtern